EPISODE · Dec 20, 2024 · 25 MIN
KAMPER: Kuvan (BH4) in phenylketonuria
from JIMD Podcasts · host Journal of Inherited Metabolic Disease
Dr François Feillet returns to the podcast to discuss the final results of the KAMPER study, evaluating the long-term safety of sapropterin in phenylketonuria (phenylalanine hydroxylase deficiency). Long-term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan® Adult Maternal Paediatric European Registry multinational observational study François Feillet, et al https://doi.org/10.1002/jimd.12796
NOW PLAYING
KAMPER: Kuvan (BH4) in phenylketonuria
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m